Patents by Inventor Don Wigington

Don Wigington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating breast cancer using a combination of vitamin D analogues and other agents
    Patent number: 7094775
    Abstract: The invention provides therapeutic methods for inhibiting, ameliorating or alleviating the hyperproliferative cellular activity of diseases of the breast, e.g., breast cancer, which includes administering to a patient in need thereof an active vitamin D analogue and another anticancer agent. Cell differentiation is promoted, induced or enhanced without causing to the patient dose-limiting hypercalcemia and hypercalciuria.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: August 22, 2006
    Assignee: Bone Care International, LLC
    Inventors: Stephen A. Strugnell, Don Wigington
  • METHOD OF TREATING BREAST CANCER USING A COMBINATION OF VITAMIN D ANALOGUES AND OTHER AGENTS
    Publication number: 20060003021
    Abstract: The invention provides therapeutic methods for inhibiting, ameliorating or alleviating the hyperproliferative cellular activity of diseases of the breast, e.g., breast cancer, which includes administering to a patient in need thereof an active vitamin D analogue and another anticancer agent. Cell differentiation is promoted, induced or enhanced without causing to the patient dose-limiting hypercalcemia and hypercalciuria.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 5, 2006
    Applicant: Bone Care International, Inc.
    Inventors: Stephen Strugnell, Don Wigington
  • Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
    Publication number: 20060003950
    Abstract: The invention provides therapeutic methods for inhibiting, ameliorating or alleviating the hyperproliferative cellular activity of diseases of the prostate, e.g., prostatic cancer and prostatic hyperplasia, which includes administering to a patient in need thereof an active vitamin D analogue and another anticancer agent. Cell differentiation is promoted, induced or enhanced without causing to the patient dose-limiting hypercalcemia and hypercalciuria.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 5, 2006
    Applicant: Bone Care International, Inc.
    Inventors: Stephen Strugnell, Don Wigington